Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1989-04-06
1991-06-25
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 8591, A61K 4902
Patent
active
050265377
ABSTRACT:
This invention pertains to a method of imaging atherosclerotic plaque using radiolabeled monoclonal antibodies that are specific for activated platelets or activated endothelial cells. The method is capable of determining the site of endothelial injury. This method involves the administration of a platelet-specific labeled monoclonal antibody or antibody fragment to a patient. The antibody is allowed to accumulate at the plaque site and the plaque is then scanned with a photoscanner. The detected signals are then converted into an image of the plaque.
REFERENCES:
patent: 3875299 (1975-04-01), Winchell et al.
patent: 4036945 (1977-07-01), Haber
patent: 4359453 (1982-11-01), Gordon
patent: 4577636 (1986-03-01), Spears
patent: 4610241 (1986-09-01), Gordon
patent: 4820505 (1989-04-01), Ginsberg et al.
patent: 4877599 (1989-10-01), Lees
McEver et al., J. Biol. Chem. 258:5269-5275 (1983).
McEver and Martin, J. Biol. Chem. 259:9799-9804 (1984).
Stenberg et al., J. Cell Biol: 101:880-886 (1985).
Berger Harvey J.
Daddona Peter E.
McEver Rodger P.
Centocor, Inc.
Maples John S.
LandOfFree
Methods for imaging atherosclerotic plaque does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for imaging atherosclerotic plaque, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for imaging atherosclerotic plaque will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1038746